1. Academic Validation
  2. Highly Reactive Group I Introns Ubiquitous in Pathogenic Fungi

Highly Reactive Group I Introns Ubiquitous in Pathogenic Fungi

  • J Mol Biol. 2024 Mar 4:168513. doi: 10.1016/j.jmb.2024.168513.
Tianshuo Liu 1 Anna Marie Pyle 2
Affiliations

Affiliations

  • 1 Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, 06520, USA.
  • 2 Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, 06520, USA; Department of Chemistry, Yale University, New Haven, CT, 06520, USA; Howard Hughes Medical Institute, Yale University, New Haven, CT, 06520, USA. Electronic address: anna.pyle@yale.edu.
Abstract

Systemic Fungal infections are a growing public health threat, and yet viable Antifungal drug targets are limited as fungi share a similar proteome with humans. However, features of RNA metabolism and the noncoding transcriptomes in fungi are distinctive. For example, fungi harbor highly structured RNA elements that humans lack, such as self-splicing introns within key housekeeping genes in the mitochondria. However, the location and function of these mitochondrial riboregulatory elements has largely eluded characterization. Here we used an RNA-structure-based bioinformatics pipeline to identify the group I introns interrupting key mitochondrial genes in medically relevant fungi, revealing their fixation within a handful of genetic hotspots and their ubiquitous presence across divergent phylogenies of fungi, including all highest priority pathogens such as Candida albicans, Candida auris, Aspergillus fumigatus and Cryptococcus neoformans. We then biochemically characterized two representative introns from C. albicans and C. auris, demonstrating their exceptionally efficient splicing catalysis relative to previously-characterized group I introns. Indeed, the C. albicans mitochondrial intron displays extremely rapid catalytic turnover, even at ambient temperatures and physiological magnesium ion concentrations. Our results unmask a significant new set of players in the RNA metabolism of pathogenic fungi, suggesting a promising new type of Antifungal drug target.

Figures
Products